PATENT CLAIM ANALYSIS

Application Number: 15746182
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2019-03
Patent Classification: ["544", "008000"]

Abstract:
The invention provides a series of chlorobenzene substituted azaaryl compounds having activity in inhibiting cancer cell growth and low toxicity to normal cells. Particularly, the compounds of the invention have stronger inhibition effect on bladder cancer and liver cancer.

Claim (Index 7):
The compound of  claim 1 , wherein X is C or N; R1 is NR7R8 wherein R7 is C1-10alkylpiperazinylphenyl, piperidinylC1-10alkyl, C1-10alkylpiperazinylC1-10alkyl or C1-10alkylpiperazinylcarbonylphenyl and R8 is H; R2 is H, halo or phenyl; R3 and R4 are each independently C1-10alkyl; and R5 and R6 are each independently H or C1-10alkyl.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 86.0
- Lexical Diversity: 1.23529
- Patent Class: 544.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15230700', '13391148', '11570966', '13575799', '15181903']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7395690053697068
- 35 USC 102 Novelty (BERT): 0.5151536754988149
- Combined Prediction Score: 0.7171274723826176
- Mean Citation Score: 260.94092800000004
- Max Citation Score: 291.13596
- Similarity Product: 213.6673044372797

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test